Archives
RSNA: Levothyroxine Tied to Bone Loss Over Time in Older Adults
Authors say findings may be due to relative excess of thyroid hormone even when treatment is targeted to reference range goals
AHA: Muvalaplin Reduces Lipoprotein(a) Levels in Individuals With Cardiovascular Risk
Reduction in levels seen using an intact lipoprotein(a) assay and apolipoprotein(a)-based assay
AHA: Half of U.S. Adults Are Eligible for Treatment With Semaglutide
More than 39 million U.S. adults qualify for indications other than weight management alone
AHA: Initial Catheter Ablation Beneficial for Ventricular Tachycardia
Initial strategy of catheter ablation leads to lower risk for composite primary end point versus antiarrhythmic drug therapy
AHA: Tirzepatide Beneficial for Heart Failure With Preserved EF, Obesity
Lower risk for composite of death from cardiovascular causes or worsening heart failure seen with tirzepatide versus placebo
AHA: Intensive Strategy for Lowering Systolic BP Beneficial in Type 2 Diabetes
Significantly lower incidence of major cardiovascular events seen with intensive- versus standard-treatment strategy
ACR: Inebilizumab Reduces Risk for Flares in IgG4-Related Disease
Flare-free, treatment-free complete remission and flare-free, glucocorticoid-free complete remission improved with inebilizumab
ACR: Colchicine No Benefit for Painful Knee Osteoarthritis
No significant improvements seen in knee pain, function, or size of synovial effusions versus placebo
AHA: Rising Outdoor Temperatures Tied to Higher Risk for Atrial Fibrillation
Doubling to tripling of odds seen when temperatures reach extreme heat levels
AHA: AI Analysis of Images, Videos Can ID Early Hypertension, Diabetes
Authors say technology may enable noninvasive screening
